ResMed Inc.
ResMed Inc. (RMD) — Form 8-K: Current report
AI-generated summary
ResMed Inc. reported on events from its annual meeting held on November 18, 2026, including the retirement of director Ronald Taylor and the reduction of the board size from eleven to ten directors. Shareholders elected ten directors, ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approved executive compensation on an advisory basis. Additionally, the company's compensation committee approved a new form of performance-based restricted stock unit award agreement for fiscal year 2027 grants to named executive officers.
Key facts
- Item 5.02 · Executive or director change or pay arrangement
- Item 5.07 · Shareholder vote results
- Item 9.01 · Financial statements and exhibits
More RMD filings
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.